Annals of Surgical Oncology

, Volume 14, Issue 7, pp 1980–1990 | Cite as

Oncologic Results of Laparoscopic D3 Lymphadenectomy for Male Sigmoid and Upper Rectal Cancer with Clinically Positive Lymph Nodes

  • Jin-Tung Liang
  • Kuo-Chin Huang
  • Hong-Shiee Lai
  • Po-Huang Lee
  • Chia-Tung Sun
Gastrointestinal Oncology



Many Japanese surgeons routinely perform extended D3 lymph node dissection for the treatment of advanced rectosigmoid cancer with a view to achieving better tumor control. However, the application of a laparoscopic approach to perform D3 lymphadenectomy has been challenging. This phase 2 prospective study aimed to explore the oncologic results of this surgical approach.


The study was conducted during a 6-year period, in consideration of median follow-up time being >3 years. The study subjects were tumor, node, metastasis system stage III rectosigmoid cancer staged by clinical images. The extent of D3 dissection and the postoperative lymph node mapping were according to the guidelines of the Japanese Society for Cancer of the Colon and Rectum. Patients were stratified according to the histopathologically proved highest level of involved lymph nodes and placed into N0, N1, N2, and N3 groups. The primary end points of the study were the estimated time to recurrence and 5-year recurrence rate of cancer after laparoscopic D3 dissection.


The estimated 5-year recurrence rate (20% in the N0 group [n = 10]; 25% in N1 [n = 44]; 33.3% in N2 [n = 30]; and 42.8% in N3 [n = 14]), time to recurrence (mean [95% confidence interval] 59.8 [42.6–76.9] months in the N0 group; 56.8 [48.3–65.2] months in N1; 46.8 [37.5–56.1] months in N2; and 43.9 [28.3–59.4] months in N3), and recurrence patterns were without significant difference (all P values >.05) among N0, N1, N2, and N3 groups. Therefore, by laparoscopic wide anatomic dissection, patients with lymph node involvement could be treated as well as those without lymph node metastasis. Laparoscopic D3 dissection facilitated the collection of more lymph nodes (mean ± standard deviation, 27.4 ± 4.2) for histopathologic examination. Mapping of dissected lymph nodes showed that 18.2% (16 of 88) patients had skip lymph node metastasis. D3 dissection facilitated upstaging of cancer (from N0 to N3) in five patients (5.1%). However, this procedure resulted in transient voiding dysfunction in 77.5% patients and loss of ejaculatory function in 91.7%. By laparoscopic approach, the D3 lymph node dissection was safely performed through small wounds, resulting in quick functional recovery and only moderate blood loss (324.8 ± 44.5 mL), but at the expense of a long operation time (294.4 ± 34.8 minutes).


The good short-term oncologic results and quick convalescence mean that the laparoscopic D3 dissection may be recommended for patients with stage III rectosigmoid cancer who could accept the genitourinary dysfunction.


Laparoscopic surgery N3 lymph node D3 lymphadenectomy Rectal cancer 


  1. 1.
    Scholefield JH, Steup WH. Surgery for rectal cancer in Japan. Lancet 1992; 340:1101PubMedCrossRefGoogle Scholar
  2. 2.
    Cady B. Basic principles in surgical oncology. Arch Surg 1997; 132:338–46PubMedGoogle Scholar
  3. 3.
    Scholefield JH, Northover JMA. Surgical management of rectal cancer. Br J Surg 1995; 82:745–8PubMedCrossRefGoogle Scholar
  4. 4.
    Grinnell RS. Results of ligation of inferior mesenteric artery at the aorta in resections of carcinoma of the descending and sigmoid colon and rectum. Surg Gynecol Obstet 1965; 120:1031–6PubMedGoogle Scholar
  5. 5.
    Glass RE, Ritchie JK, Thompson HR, et al. The results of surgical treatment of cancer of the rectum by radical resection and extended abdomino-iliac lymphadenectomy. Br J Surg 1985; 72:599–601PubMedCrossRefGoogle Scholar
  6. 6.
    Cosimelli M, Mannella E, Giannarelli D, et al. Nerve-sparing surgery in 302 resectable rectosigmoid cancer patients: genitourinary morbidity and 10-year survival. Dis Colon Rectum 1994; 37:S42–6PubMedCrossRefGoogle Scholar
  7. 7.
    Harnsberger JR, Vernava VM 3rd, Longo WE. Radical abdominopelvic lymphadenectomy: historic perspective and current role in the surgical management of rectal cancer. Dis Colon Rectum 1994; 37:73–87PubMedCrossRefGoogle Scholar
  8. 8.
    Havenga K, Enker WE, McDermott K, Cohen AM, Minsky BD, Guillem J. Male and female sexual and urinary function after total mesorectal excision with autonomic nerve preservation for carcinoma of the rectum. J Am Coll Surg 1996; 182:495–502PubMedGoogle Scholar
  9. 9.
    Sugihara K, Moriya Y, Akasu T, Fujita S. Pelvic autonomic nerve preservation for patients with rectal carcinoma. Oncologic and functional outcome. Cancer 1996; 78:1871–80PubMedCrossRefGoogle Scholar
  10. 10.
    Liang JT, Lai HS, Lee PH. Laparoscopic pelvic autonomic nerve-preserving surgery for patients with lower rectal cancer after chemoradiation therapy. Ann Surg Oncol (in press)Google Scholar
  11. 11.
    Yasutomi M. Advances in rectal cancer surgery in Japan. Dis Colon Rectum 1997; 40:S74–9PubMedCrossRefGoogle Scholar
  12. 12.
    Moriya Y. Pelvic dissection with autonomic nerve sparing for invasive lower rectal cancer: Japanese experience. In: Wanebo HJ, eds. Colorectal Cancer. St Louis: Mosby-Year Book, 1993:274–89Google Scholar
  13. 13.
    Akasu T, Moriya Y. Abdominopelvic lymphadenectomy with automic nerve perserration for carcinoma of the rectum: Japanese experience. In: Wanebo HJ, ed. Surgery for Gastroinestinal Cancer: A Multidisplinary Apporoach. Philadephia: Lippicott-Raven, 1997:667–80Google Scholar
  14. 14.
    Takahashi T, Ueno M, Azekura K, Ota H. The lymphatic spread of rectal cancer and the effect of dissection: Japanese contribution and experience. In: Soreide O, Norstein J, eds. Rectal Cancer Surgery. Berlin: Springer, 1997:165–80Google Scholar
  15. 15.
    Japanese Society for Cancer of the Colon and Rectum. General Rules for Clinical and Pathological Studies on Cancer of the Colon, Rectum, and Anus. Tokyo: Kanehara, 1994Google Scholar
  16. 16.
    Hida J, Yasutomic M, Maruyama T, et al. Indication for using high ligation of the inferior mesenteric artery in rectal cancer surgery. Dis Colon Rectum 1998; 41:984–91PubMedCrossRefGoogle Scholar
  17. 17.
    Moriya Y, Hojo K, Sawada T, Koyama Y. Significance of lateral node dissection for advanced rectal carcinoma at or below the peritoneal reflection. Dis Colon Rectum 1989; 32:307–15PubMedCrossRefGoogle Scholar
  18. 18.
    Maas CP, Moriya Y, Steup WH, Kiebert GM, Kranenbarg WM, van de Velde CJ. Radical and nerve-preserving surgery for rectal cancer in The Netherlands: a prospective study on morbidity and functional outcome. Br J Surg 1998; 85:92–7PubMedCrossRefGoogle Scholar
  19. 19.
    Shirouzu K, Isomoto H, Kakegana T. Prognostic evaluation of perineural invasion in rectal cancer. Am J Surg 1993; 165:233–7PubMedCrossRefGoogle Scholar
  20. 20.
    Yamakoshi H, Ike H, Oki S, Hara M, Shimada H. Metastasis of rectal cancer to lymph nodes and tissues around the autonomic nerves spared for urinary and sexual function. Dis Colon Rectum 1997; 40:1079–84PubMedCrossRefGoogle Scholar
  21. 21.
    Ueno H, Mochizuki H, Tamakuma S. Prognostic significance of extranodal microscopic foci discontinuous with primary lesion in rectal cancer. Dis Colon Rectum 1998; 41:55–61PubMedCrossRefGoogle Scholar
  22. 22.
    Ueno H, Yamauchi C, Hase K, Ichikura T, Mochizuki H. Clinicopathological study of intrapelvic cancer spread to the iliac area in lower rectal adenocarcinoma by serial sectioning. Br J Surg 1999; 86:1532–7PubMedCrossRefGoogle Scholar
  23. 23.
    Ueno H, Mochizuki H, Fujimoto H, Hase K, Ichikura T. Autonomic nerve plexus involvement and prognosis in patients with rectal cancer. Br J Surg 2000; 87:92–6PubMedCrossRefGoogle Scholar
  24. 24.
    Ueno H, Hase K, Mochizuki H. Criteria for extramural perineural invasion as a prognostic factor in rectal cancer. Br J Surg 2001; 88:994–1000PubMedCrossRefGoogle Scholar
  25. 25.
    Ueno M, Oya M, Azekura K, Yamaguchi T, Muto T. Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancer. Br J Surg 2005; 92:756–63PubMedCrossRefGoogle Scholar
  26. 26.
    Le Voyer TE, Sigurdson ER, Hanlon AL, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol 2003; 21:2912–9PubMedCrossRefGoogle Scholar
  27. 27.
    Nelson H, Petrelli N, Carlin A, et al. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 2001; 93:583–96PubMedCrossRefGoogle Scholar
  28. 28.
    Andre T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004; 350:2343–51PubMedCrossRefGoogle Scholar
  29. 29.
    Mori T, Hirota T, Ohashi Y, et al. Significance of histologic type of primary lesion and metastatic lymph nodes as a prognostic factor in stage III colon cancer. Dis Colon Rectum 2006; 49:982–92PubMedCrossRefGoogle Scholar
  30. 30.
    Kobayashi M, Okamoto K, Namikawa T, Okabayashi T, Araki K. Laparoscopic lymph node dissection around the inferior mesenteric artery for cancer in the lower sigmoid colon and rectum: is D3 lymph node dissection with preservation of the left colic artery feasible? Surg Endosc 2006; 20:563–9PubMedCrossRefGoogle Scholar
  31. 31.
    Liang JT, Lai HS, Huang KC, et al. Comparison of medial-to-lateral versus traditional lateral-to-medial laparoscopic dissection sequences for resection of rectosigmoid cancers: randomized controlled clinical trial. World J Surg 2003; 27:190–6PubMedCrossRefGoogle Scholar
  32. 32.
    Liang JT, Lai HS, Lee PH. Laparoscopic total mesorectal excision for rectal cancers. Dis Colon Rectum 2006; 49:517–8CrossRefGoogle Scholar
  33. 33.
    Liang JT, Huang KH, Lai HS, Lee PH, Jeng YM. Oncologic results of laparoscopic versus conventional open surgery for advanced curable left-sided colon cancers: a randomized controlled trial. Ann Surg Oncol 2007; 14:109–17PubMedCrossRefGoogle Scholar
  34. 34.
    Sargent DJ, Wieand HS, Haller DG, et al. Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol 2005; 23:8664–70PubMedCrossRefGoogle Scholar
  35. 35.
    Kim JH, Beets GL, Kim MJ, Kessels AG, Beets-Tan RG. High-resolution MR imaging for nodal staging in rectal cancer: are there any criteria in addition to the size? Eur J Radiol 2004; 52:78–83PubMedCrossRefGoogle Scholar
  36. 36.
    Tang R, Wang JY, Chen JS, et al. Survival impact of lymph node metastases in TNM stage III carcinoma of the colon and rectum. J Am Coll Surg 1995; 180:705–12PubMedGoogle Scholar
  37. 37.
    Miki C, Hiro J, Ojima E, Inoue Y, Mohri Y, Kusunoki M. Perioperative allogeneic blood transfusion, the related cytokine response and long-term survival after potentially curative resection of colorectal cancer. Clin Oncol (R Coll Radiol) 2006; 18:60–6Google Scholar
  38. 38.
    Reza MM, Blasco JA, Andradas E, Cantero R, Mayol J. Systematic review of laparoscopic versus open surgery for colorectal cancer. Br J Surg 2006; 93:921–8PubMedCrossRefGoogle Scholar
  39. 39.
    Tsioulias GJ, Wood TF, Morton DL, Bilchik AJ. Lymphatic mapping and focused analysis of sentinel lymph nodes upstage gastrointestinal neoplasms. Arch Surg 2000; 135:926–32PubMedCrossRefGoogle Scholar
  40. 40.
    Bilchik AJ, Saha S, Tsioulias GJ, Wood TF, Morton DL. Aberrant drainage and missed micrometastases: the value of lymphatic mapping and focused analysis of sentinel lymph nodes in gastrointestinal neoplasms. Ann Surg Oncol 2001; 8(Suppl):82S–5SPubMedGoogle Scholar
  41. 41.
    Merrie AE, Phillips LV, Yun K, McCall JL. Skip metastases in colon cancer: assessment by lymph node mapping using molecular detection. Surgery 2001; 129:684–91PubMedCrossRefGoogle Scholar
  42. 42.
    Saha S, Bilchik A, Wiese D, et al. Ultrastaging of colorectal cancer by sentinel lymph node mapping technique—a multicenter trial. Ann Surg Oncol 2001; 8(Suppl):94S–8SPubMedGoogle Scholar
  43. 43.
    Bertagnolli M, Miedema B, Redston M, et al. Sentinel node staging of resectable colon cancer: results of a multicenter study. Ann Surg 2004; 240:624–8PubMedGoogle Scholar
  44. 44.
    Guillou PJ, Quirke P, Thorpe H, et al. MRC CLASICC trial group. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet 2005; 365:1718–26PubMedCrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2007

Authors and Affiliations

  • Jin-Tung Liang
    • 1
  • Kuo-Chin Huang
    • 2
  • Hong-Shiee Lai
    • 1
  • Po-Huang Lee
    • 1
  • Chia-Tung Sun
    • 3
  1. 1.Department of Surgery, Division of Colorectal SurgeryNational Taiwan University Hospital and College of MedicineTaipeiROC
  2. 2.Department of Family MedicineNational Taiwan University Hospital and College of MedicineTaipeiROC
  3. 3.Department of PathologyNational Taiwan University Hospital and College of MedicineTaipeiROC

Personalised recommendations